Company Filing History:
3 out of 3 
1 out of 22 
1 out of 30 Years Active: 2017-2025
Title: The Innovative Mind of Min Han: Shaping Biotechnology in Shanghai
Introduction: Min Han is an accomplished inventor based in Shanghai, China, renowned for his contributions to the field of biotechnology. With a total of 4 patents to his name, he has made significant strides in understanding complex biological mechanisms, particularly those associated with obesity and G-protein coupled receptors.
Latest Patents: Among his latest patents, the application of the GPR45 gene stands out. This groundbreaking invention explores the correlation between the GPR45 gene and obesity. For the first time, it reveals that knocking out or reducing the expression of the GPR45 gene may lead to obesity. Furthermore, Min Han established an obese mouse model by blocking the expression of the GPR45 gene, offering a more accurate representation of obesity mechanisms in humans. This model holds promise for drug screening aimed at treating obesity.
Another noteworthy patent involves a novel method of expressing G-protein coupled receptor (GPCR) proteins. Han's invention focuses on fusion proteins that enhance the expression of GPCRs using different protein fragments. These innovations improve protein yield and stability during purification, demonstrating their applicability in GPCR research.
Career Highlights: Throughout his career, Min Han has made significant contributions while working with reputable companies such as Viva Biotech, where he leveraged his expertise in biotechnological advancements. His innovative spirit has fueled his work in various projects, positioning him as a remarkable figure in the industry.
Collaborations: Collaboration has been a key element in Min Han's success. Co-working with notable professionals like Jianhua Cai and Jian Shen, he has been able to drive forward innovative projects and research initiatives that push the boundaries of biotechnology.
Conclusion: Min Han's contributions to biotechnology through his inventiveness and research have marked him as an important inventor in the field. His work on the GPR45 gene and GPCR proteins not only enhances our understanding of biological processes but also paves the way for future innovations aimed at addressing obesity and improving drug development. His endeavors in Shanghai continue to inspire the next generation of inventors and innovators within the biotechnology sector.